HealthEquity (NASDAQ:HQY) Price Target Cut to $100.00 by Analysts at Royal Bank Of Canada

HealthEquity (NASDAQ:HQY) had its price target lowered by Royal Bank Of Canada from $110.00 to $100.00 in a research note published on Wednesday,Benzinga reports. Royal Bank Of Canada currently has an outperform rating on the stock.

HQY has been the subject of a number of other reports. UBS Group set a $110.00 price objective on shares of HealthEquity in a research report on Tuesday, February 17th. BTIG Research cut their price target on HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. JPMorgan Chase & Co. increased their price target on HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a research note on Monday, January 19th. Finally, Barclays dropped their price objective on HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday, February 18th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $109.79.

HealthEquity Trading Up 0.2%

NASDAQ HQY opened at $79.57 on Wednesday. The stock has a market cap of $6.80 billion, a P/E ratio of 32.35, a PEG ratio of 0.99 and a beta of 0.26. The company’s fifty day simple moving average is $80.93 and its 200-day simple moving average is $90.20. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. HealthEquity has a 52 week low of $72.76 and a 52 week high of $116.65.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.05. HealthEquity had a net margin of 16.39% and a return on equity of 13.82%. The business had revenue of $334.59 million during the quarter, compared to analyst estimates of $332.48 million. HealthEquity’s revenue was up 7.3% on a year-over-year basis. Equities research analysts predict that HealthEquity will post 2.32 EPS for the current fiscal year.

Insider Activity

In related news, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.50% of the company’s stock.

Institutional Trading of HealthEquity

Institutional investors and hedge funds have recently bought and sold shares of the company. William Blair Investment Management LLC acquired a new position in shares of HealthEquity in the 4th quarter worth approximately $169,956,000. Norges Bank acquired a new stake in shares of HealthEquity during the 4th quarter valued at approximately $66,927,000. Westfield Capital Management Co. LP lifted its stake in HealthEquity by 124.6% during the second quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after purchasing an additional 701,819 shares during the last quarter. AQR Capital Management LLC lifted its stake in HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after purchasing an additional 661,795 shares during the last quarter. Finally, Millennium Management LLC boosted its holdings in HealthEquity by 151.5% in the fourth quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock worth $87,173,000 after purchasing an additional 573,283 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

Key HealthEquity News

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Q4 results beat expectations and management raised guidance — HQY reported $0.95 EPS vs. $0.90 consensus and revenue of $334.6M (vs. ~$332.5M expected); revenue was up ~7% y/y and the company raised fiscal 2027 outlook after record revenue and net income growth. Press Release
• Positive Sentiment: Earnings call highlighted operational strength — company cited record HSA growth and “improved cash economics” and other call takeaways that support the raised guidance and margin expansion. Earnings Highlights
• Positive Sentiment: Independent upgrade — Seeking Alpha published a rating upgrade citing improved cash dynamics, which can support investor sentiment and multiple expansion. SA Upgrade
• Neutral Sentiment: Full earnings/transcript availability — multiple transcripts and analyst writeups are live (useful for digging into guidance, margins, and HSA metric details). Earnings Transcript
• Negative Sentiment: Barrington trimmed its price target from $125 to $110 (still an “outperform”) — the cut narrows analyst-implied upside vs. prior target and may cap near-term upside. Benzinga Note
• Negative Sentiment: JPMorgan lowered its target from $129 to $123 but remains “overweight” — another downward revision in targets that could weigh on sentiment despite maintaining a positive rating. Benzinga TickerReport
• Negative Sentiment: RBC cut its target from $110 to $100 (still “outperform”) — another analyst trimming targets, which may limit immediate upside until guidance execution is proven. Benzinga Note

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.